Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health.

November 2, 2022 updated by: Anne Monique NUYT,MD, St. Justine's Hospital

Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health

In spite of advances in neonatal intensive care allowing the first generation survivors of extreme prematurity to now reach young adulthood, these individuals present with reduced exercise capacity; a strong predictor of later chronic disease and mortality. The reason why individuals born preterm have exercise limitation remains unclear and may be a consequence of impact of preterm birth and associated neonatal difficulties on the development of organs important for exercise, namely the lungs, the heart, the vessels (which bring blood and oxygen to the muscles) and the muscles. It is well known that exercise benefits overall health in at-risk as well diseased populations. However, whether exercise training can improve fitness in young adults born preterm was not demonstrated and whether the cardiovascular, pulmonary and muscle impairments associated with preterm birth are reversible through exercise intervention in young adulthood is unknown.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The investigators postulate that a 14-week exercise intervention will improve exercise capacity in preterm adults, as seen in other at-risk populations, in correlation with measures of vascular health, heart and muscle perfusion and oxygenation, and pulmonary function detected by cutting edge and highly sensitive imaging and circulating biomarkers. These markers are more sensitive to pre-disease changes than traditional health measures, and are largely unexplored in preterm populations.

The investigators will:

  1. Determine whether a 14-week supervised exercise training improves exercise capacity in young adults (18-29 years old) born very preterm at <29 weeks gestational age.
  2. Examine whether improvement in exercise capacity is associated with changes in (a) markers of vascular health including circulating endothelial progenitor cells and microparticles, (b) cardiac perfusion by cutting-edge oxygenation-sensitive cardiovascular magnetic resonance imaging (MRI), (c) lung regional ventilation measured by newly developed hydrogen proton (1H) MRI, (d) muscle oxygenation during exercise.
  3. Compare the response of the above measures to exercise intervention between young adults born very preterm and term controls.

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montréal, Quebec, Canada, H3T1C5
        • St. Justine's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 29 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Both groups :

  • Aged between 18-29 years old
  • Less than 120 minutes of exercise per week
  • Willingness to be part of the 14 weeks exercise intervention

Preterm group:

- Born under 29 weeks of gestation

Term group :

  • Born between 37-41 weeks
  • Appropriate weight fo gestational weight

Exclusion Criteria:

  • Pregnancy
  • conditions excludins individual from exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: young adults
Both young adults born preterm (n=60) and term (n=30) will undergo the exercise intervention.
Assigned intervention : 14-week supervised intervention of aerobic and resistance training.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
Respiratory exchange ratio (RER) (%)
16 weeks
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
Oxygen uptake (VO2max) (mL/min)
16 weeks
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
Carbon dioxide production (VCO2) (L/min)
16 weeks
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
VO2peak (mL/kg/min)
16 weeks
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
Weight (kg)
16 weeks
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
Height (cm)
16 weeks
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
Age (years)
16 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiac oxygen sensitive MRI (OS-MRI)
Time Frame: 18 weeks
myocardial perfusion in response to CO2 modulation
18 weeks
Lung regional ventilation using a 3D proton MRI ultrashort ecotime
Time Frame: 1 week
Parenchyma signal intensity (SI)
1 week
Muscle oxygenation
Time Frame: 18 weeks
Near-infrared spectroscopy (NIRS)
18 weeks
Pulmonary function
Time Frame: 18 weeks
Forced spirometry (FEV1, L)
18 weeks
Pulmonary function
Time Frame: 18 weeks
Forced spirometry (FVC, L)
18 weeks
Pulmonary function
Time Frame: 18 weeks
Forced spirometry (FEF25-75, L/s)
18 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2018

Primary Completion (Actual)

January 18, 2021

Study Completion (Actual)

January 27, 2021

Study Registration Dates

First Submitted

April 10, 2018

First Submitted That Met QC Criteria

April 19, 2018

First Posted (Actual)

April 20, 2018

Study Record Updates

Last Update Posted (Actual)

November 3, 2022

Last Update Submitted That Met QC Criteria

November 2, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prematurity; Extreme

Clinical Trials on Exercise Intervention

3
Subscribe